Brief: Sutro Biopharma posts Q1 basic EPS USD -0.85
15/05/2023 13:01
May 15 (Reuters) - Sutro Biopharma Q1 revenue USD 12.674 million. * Q1 basic EPS USD -0.85 * Q1 net income USD -50.05 million * Q1 operating income USD -42.237 million * Q1 operating expenses USD 54.911 million
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates